Literature DB >> 32173495

Taxonomic identification and bioactive compounds characterization of Psilocybe cubensis DPT1 to probe its antibacterial and mosquito larvicidal competency.

Dharumadhurai Dhanasekaran1, Selvanathan Latha2, Packkrisamy Suganya3, Annamalai Panneerselvam4, Thiruppathi Senthil Kumar5, Naiyf S Alharbi6, Chinnathambi Arunachalam6, Sulaiman Ali Alharbi6, Nooruddin Thajuddin7.   

Abstract

Mushrooms have an important role in sustainability since they have long been used as valuable food source and traditional medicine around the world. Regrettably, they are among the most rigorously affected populations, along with several plants and animals, due to the destructive activities of mankind. Thus the authentication and conservation of mushroom species are constantly needed to exploit the remarkable potential in them. In this perspective, an attempt has been made to identify and assess the biological attributes of psychedelic mushrooms collected from Kodaikanal, Tamil Nadu, India. The macromorphological features of the psychedelic mushroom DPT1 helped its presumptive identification and the molecular characters depicted by DNA marker revealed its close relationship with the genus Psilocybe. Accordingly, the psychedelic mushroom was identified as Psilocybe cubensis DPT1 and its crude ethyl acetate extract on analysis revealed the occurrence of phytoconstituents like alkaloids, flavonoids, tannins, saponins and carbohydrates. Moreover, it exhibited 80% larvicidal activity against Culex quinquefasciatus mosquito at 800 ppm concentration and an array of antibacterial effects with utmost susceptibility of Proteus vulgaris, and the identification of bioactive compounds by different analytical techniques substantiate that the bioactivities might be due to the presence of phytochemicals. The results of the study indicated that the extract of P. cubensis DPT1 having notable antibacterial and mosquito larvicidal efficacies which could be probed further for the isolation of medicinally important as well as bio-control compounds.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Pharmacological properties; Psilocybe cubensis DPT1; Psychedelic mushroom; Taxonomy

Year:  2020        PMID: 32173495     DOI: 10.1016/j.micpath.2020.104138

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  3 in total

1.  Effects and safety of Psilocybe cubensis and Panaeolus cyanescens magic mushroom extracts on endothelin-1-induced hypertrophy and cell injury in cardiomyocytes.

Authors:  Sanah M Nkadimeng; Christiaan M L Steinmann; Jacobus N Eloff
Journal:  Sci Rep       Date:  2020-12-18       Impact factor: 4.379

2.  Anti-Inflammatory Effects of Four Psilocybin-Containing Magic Mushroom Water Extracts in vitro on 15-Lipoxygenase Activity and on Lipopolysaccharide-Induced Cyclooxygenase-2 and Inflammatory Cytokines in Human U937 Macrophage Cells.

Authors:  Sanah Malomile Nkadimeng; Christiaan M L Steinmann; Jacobus N Eloff
Journal:  J Inflamm Res       Date:  2021-08-05

Review 3.  Antioxidant Activity of Mushroom Extracts/Polysaccharides-Their Antiviral Properties and Plausible AntiCOVID-19 Properties.

Authors:  Sechul Chun; Judy Gopal; Manikandan Muthu
Journal:  Antioxidants (Basel)       Date:  2021-11-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.